Credit Agricole’s Inovio Pharmaceuticals INO Stock Holding History

Credit Agricole’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-667	Closed	-$3.11K	–	958
2023 Q3	$3.11K	Hold	667	–	–	﹤0.01%	881
2023 Q2	$3.57K	Hold	667	–	–	﹤0.01%	656
2023 Q1	$6.56K	Hold	667	–	–	﹤0.01%	600
2022 Q4	$12.5K	Hold	667	–	–	﹤0.01%	609
2022 Q3	$14K	Hold	667	–	–	﹤0.01%	588
2022 Q2	$14K	Hold	667	–	–	﹤0.01%	589
2022 Q1	$29K	Hold	667	–	–	﹤0.01%	574
2021 Q4	$40K	Hold	667	–	–	﹤0.01%	547
2021 Q3	$57K	Sell	667 -833	-56%	-$83.6K	﹤0.01%	489
2021 Q2	$167K	Buy	1,500 +417	+39%	+$40.1K	﹤0.01%	380
2021 Q1	$121K	Buy	1,083 +750	+225%	+$98.6K	﹤0.01%	377
2020 Q4	$35K	Buy	+333	New	+$44.3K	﹤0.01%	421

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Agricole's INO Position: Q4 2023 in Review

Credit Agricole sold out of Inovio Pharmaceuticals (INO) in Q4 2023, closing a stake of 667 shares — an estimated $3.11K sold.

Credit Agricole first reported a position in INO in Q4 2020 and held it in 12 quarters. The position peaked at $167K in Q2 2021. 113 funds tracked by Wall St. Rank hold INO as of Q4 2023.

Credit Agricole reported no remaining Inovio Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Credit Agricole sold 667 Inovio Pharmaceuticals shares in Q4 2023, an estimated $3.11K.
Credit Agricole first reported a position in Inovio Pharmaceuticals in Q4 2020 and held it in 12 quarters.
Credit Agricole's Inovio Pharmaceuticals position peaked at $167K in Q2 2021.
113 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2023.

Based on Credit Agricole's 13F filing for Q4 2023, filed 13 Feb 2024.